Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer
Phase I Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets for Patients With High Risk Prostate Cancer
Sponsor: National Institute for Biomedical Imaging and Bioengineering (NIBIB)
A PHASE1 clinical study on Prostate Cancer, this trial is ongoing. The trial is conducted by National Institute for Biomedical Imaging and Bioengineering (NIBIB) and has accumulated 19 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
19 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE1
-
Mar 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
▶ Show 14 earlier versions
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting PHASE1
-
Feb 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE1
-
Mar 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
-
Jun 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
-
Feb 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Feb 2020 [monthly]
Recruiting PHASE1
-
Feb 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute for Biomedical Imaging and Bioengineering (NIBIB)
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .